DexCom, Inc.
DXCM
$61.14
$1.813.05%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 4.82B | 4.66B | 4.52B | 4.30B | 4.15B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.82B | 4.66B | 4.52B | 4.30B | 4.15B |
| Cost of Revenue | 1.85B | 1.86B | 1.85B | 1.77B | 1.68B |
| Gross Profit | 2.96B | 2.80B | 2.67B | 2.53B | 2.47B |
| SG&A Expenses | 1.33B | 1.29B | 1.30B | 1.27B | 1.28B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.78B | 3.75B | 3.74B | 3.61B | 3.52B |
| Operating Income | 1.03B | 911.80M | 777.70M | 687.20M | 632.60M |
| Income Before Tax | 1.20B | 1.09B | 959.00M | 784.10M | 730.80M |
| Income Tax Expenses | 273.20M | 252.10M | 238.30M | 212.60M | 195.60M |
| Earnings from Continuing Operations | 930.40 | 836.30 | 720.70 | 571.50 | 535.20 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 930.40M | 836.30M | 720.70M | 571.50M | 535.20M |
| EBIT | 1.03B | 911.80M | 777.70M | 687.20M | 632.60M |
| EBITDA | 1.29B | 1.16B | 1.02B | 923.30M | 857.80M |
| EPS Basic | 2.39 | 2.14 | 1.84 | 1.46 | 1.36 |
| Normalized Basic EPS | 1.94 | 1.75 | 1.54 | 1.26 | 1.17 |
| EPS Diluted | 2.34 | 2.09 | 1.80 | 1.43 | 1.33 |
| Normalized Diluted EPS | 1.87 | 1.69 | 1.48 | 1.21 | 1.12 |
| Average Basic Shares Outstanding | 1.56B | 1.56B | 1.56B | 1.57B | 1.58B |
| Average Diluted Shares Outstanding | 1.61B | 1.62B | 1.63B | 1.63B | 1.64B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |